Kopra Bio

Kopra BioViral immunotherapies that turn cancer cells into biofactories

Kopra Bio develops viral immunotherapy treatments for aggressive cancers, like glioblastoma. Our technology, developed at UCSF, has shown incredible promise in preclinical models, increasing survival from 0% to 90%. Learn more about our mission to revolutionize cancer treatment.

Kopra Bio screenshot

Kopra Bio

Kopra Bio is a cancer immunotherapy that turns cancer cells into biofactories that produce their own destruction.

Product Highlights

  • Feature 1: Turns cancer cells into biofactories producing their own destruction.
  • Feature 2: Enhances the body's ability to fight cancer cells.
  • Feature 3: Provides a targeted and precise cancer treatment.

Use Cases

  • Use case 1: Treatment of various cancer types.
  • Use case 2: Development of new treatments for cancer.
  • Use case 3: Provides effective cancer treatment with reduced side effects.

Target Audience

The treatment is aimed at cancer patients and healthcare professionals.

Weekly Top 10 Products